Markt geschlossen -
Andere Börsenplätze
|
% 5 Tage | % 1. Jan. | ||
0.1943 USD | -0.82% | +0.62% | +102.40% |
Terminchart Provectus Biopharmaceuticals, Inc.
Anstehende Termine für Provectus Biopharmaceuticals, Inc.
Zurückliegende Termine für Provectus Biopharmaceuticals, Inc.
05.04.2024 | American Association for Cancer Research Meeting |
22.02.2024 21:00 | Business Update Call |
06.11.2023 | Society for Melanoma Research Congress - Combination PV-10 autolytic immunotherapy |
06.11.2023 | Society for Melanoma Research Congress - Percutaneous autolytic immunotherapy |
01.11.2023 | Society for Immunotherapy of Cancer Meeting |
01.12.2022 | Melanoma Bridge Conference |
22.06.2022 22:00 | Annual Genral Meeting |
17.06.2022 | International Society of Ocular Oncology Congress |
06.06.2022 20:15 | American Society of Clinical Oncology Meeting - Abstract No 9543 |
08.04.2022 | American Association of Cancer Research Meeting - Abstract No 2720 |
10.03.2022 | European Neuroendocrine Tumor Society Conference - Abstract No: 3455, I25 |
28.10.2021 | Society for Melanoma Research Meeting - Cutaneous Melanoma |
28.10.2021 | Society for Melanoma Research Congress - Checkpoint Blockade |
16.09.2021 | ESMO Congress Conference - Abstract No - 4354 |
23.06.2021 22:00 | Annual Genral Meeting |
09.11.2020 | Society of Immunotherapy of Cancer Meeting - Abstract Number : 585 |
19.09.2020 | European Society for Medical Oncology Virtual Congress - Poster No -4397 |
19.09.2020 | European Society for Medical Oncology Virtual Congress - Poster No -4281 |
22.06.2020 | American Association for Cancer Research Virtual Meeting - Abstract number: 5393 |
29.05.2020 | American Society of Clinical Oncology Virtual Jahreshauptversammlung - Abstract No - 1 |
Zurückliegende Branchentermine für Provectus Biopharmaceuticals, Inc.
- Börse
- Aktien
- A1XCTC Aktie
- Termine Provectus Biopharmaceuticals, Inc.